Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas Patients Using Daclatasvir and Asunaprevir: A Pilot Study
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 25 Apr 2018
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 17 Apr 2018 Planned End Date changed from 1 Sep 2019 to 18 Apr 2019.
- 17 Apr 2018 Planned primary completion date changed from 1 May 2018 to 1 Jan 2018.
- 17 Apr 2018 Status changed from active, no longer recruiting to withdrawn prior to enrolment.